{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:12:45Z","timestamp":1793160765719,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD079823"],"award-info":[{"award-number":["HD079823"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"This work was supported in part by the NIMH Intramural Research Program"},{"name":"Weill NeuroHub and the Nancy and Buster Alvord Endowment","id":[{"id":"https:\/\/ror.org\/0229evh14","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P50 Ag005136"],"award-info":[{"award-number":["P50 Ag005136"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG053740"],"award-info":[{"award-number":["AG053740"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH113177"],"award-info":[{"award-number":["MH113177"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Amon G. Carter Foundation and Peterson-Coutin fund","id":[{"id":"https:\/\/ror.org\/00xege567","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Synaptic disturbances in excitatory to inhibitory (E\/I) balance in forebrain circuits are thought to contribute to the progression of Alzheimer\u2019s disease (AD) and dementia, although direct evidence for such imbalance in humans is lacking. We assessed anatomical and electrophysiological synaptic E\/I ratios in post-mortem parietal cortex samples from middle-aged individuals with AD (early-onset) or Down syndrome (DS) by fluorescence deconvolution tomography and microtransplantation of synaptic membranes. Both approaches revealed significantly elevated E\/I ratios for AD, but not DS, versus controls. Gene expression studies in an independent AD cohort also demonstrated elevated E\/I ratios in individuals with AD as compared to controls. These findings provide evidence of a marked pro-excitatory perturbation of synaptic E\/I balance in AD parietal cortex, a region within the default mode network that is overly active in the disorder, and support the hypothesis that E\/I imbalances disrupt cognition-related\u00a0shifts in cortical activity which contribute to the intellectual decline in AD.<\/jats:p>","DOI":"10.1038\/s41467-021-22742-8","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T06:04:16Z","timestamp":1620626656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8444-6151","authenticated-orcid":false,"given":"Julie C.","family":"Lauterborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scaduto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor D.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-4969","authenticated-orcid":false,"given":"Anton","family":"Schulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7727-796X","authenticated-orcid":false,"given":"Christine M.","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-1469","authenticated-orcid":false,"given":"C. Dirk","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-770X","authenticated-orcid":false,"given":"Agenor","family":"Limon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"22742_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"Alzheimer\u2019s Association","year":"2019","unstructured":"Alzheimer\u2019s Association. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 15, 321\u2013387 (2019).","journal-title":"Alzheimers Dement."},{"key":"22742_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."},{"key":"22742_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease is a synaptic failure. Science 298, 789\u2013791 (2002).","journal-title":"Science"},{"key":"22742_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop, J. J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron 55, 697\u2013711 (2007).","journal-title":"Neuron"},{"key":"22742_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret, L. et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708\u2013721 (2012).","journal-title":"Cell"},{"key":"22742_CR6","first-page":"134","volume":"4","author":"R Goutagny","year":"2013","unstructured":"Goutagny, R. & Krantic, S. Hippocampal oscillatory activity in Alzheimer\u2019s disease: toward the identification of early biomarkers? Aging Dis. 4, 134\u2013140 (2013).","journal-title":"Aging Dis."},{"key":"22742_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1528-1167.2010.02909.x","volume":"52","author":"J Noebels","year":"2011","unstructured":"Noebels, J. A perfect storm: converging paths of epilepsy and Alzheimer\u2019s dementia intersect in the hippocampal formation. Epilepsia 52, 39\u201346 (2011). Suppl 1.","journal-title":"Epilepsia"},{"key":"22742_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41593-018-0080-x","volume":"21","author":"B Styr","year":"2018","unstructured":"Styr, B. & Slutsky, I. Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer\u2019s disease. Nat. Neurosci. 21, 463\u2013473 (2018).","journal-title":"Nat. Neurosci."},{"key":"22742_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnins.2018.00046","volume":"12","author":"S Zhou","year":"2018","unstructured":"Zhou, S. & Yu, Y. Synaptic E-I balance underlies efficient neural coding. Front. Neurosci. 12, 46 (2018).","journal-title":"Front. Neurosci."},{"key":"22742_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nn.2105","volume":"11","author":"M Okun","year":"2008","unstructured":"Okun, M. & Lampl, I. Instantaneous correlation of excitation and inhibition during ongoing and sensory-evoked activities. Nat. Neurosci. 11, 535\u2013537 (2008).","journal-title":"Nat. Neurosci."},{"key":"22742_CR11","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1038\/nn.4415","volume":"19","author":"J Barral","year":"2016","unstructured":"Barral, J. & DR., A. Synaptic scaling rule preserves excitatory-inhibitory balance and salient neuronal network dynamics. Nat. Neurosci. 19, 1690\u20131696 (2016).","journal-title":"Nat. Neurosci."},{"key":"22742_CR12","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1073\/pnas.1204606109","volume":"109","author":"A Limon","year":"2012","unstructured":"Limon, A., Reyes-Ruiz, J. M. & Miledi, R. Loss of functional GABA(A) receptors in the Alzheimer diseased brain. Proc. Natl Acad. Sci. USA 109, 10071\u201310076 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22742_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1440.011","volume":"1124","author":"RL Buckner","year":"2008","unstructured":"Buckner, R. L., Andrews-Hanna, J. R. & Schacter, D. L. The brain\u2019s default network: anatomy, function, and relevance to disease. Ann. N.Y Acad. Sci. 1124, 1\u201338 (2008).","journal-title":"Ann. N.Y Acad. Sci."},{"key":"22742_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/hbm.20531","volume":"30","author":"LQ Uddin","year":"2009","unstructured":"Uddin, L. Q., Kelly, A. M., Biswal, B. B., Castellanos, F. X. & Milham, M. P. Functional connectivity of default mode network components: correlation, anticorrelation, and causality. Hum. Brain Mapp. 30, 625\u2013637 (2009).","journal-title":"Hum. Brain Mapp."},{"key":"22742_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-neuro-080317-061725","volume":"41","author":"B Zott","year":"2018","unstructured":"Zott, B., Busche, M. A., Sperling, R. A. & Konnerth, A. What happens with the circuit in Alzheimer\u2019s disease in mice and humans? Annu. Rev. Neurosci. 41, 277\u2013297 (2018).","journal-title":"Annu. Rev. Neurosci."},{"key":"22742_CR16","doi-asserted-by":"publisher","first-page":"14504","DOI":"10.1073\/pnas.2235925100","volume":"100","author":"C Lustig","year":"2003","unstructured":"Lustig, C. et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc. Natl Acad. Sci. USA 100, 14504\u201314509 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22742_CR17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1471-4159.2007.05014.x","volume":"104","author":"W Yu","year":"2008","unstructured":"Yu, W. & De Blas, A. L. Gephyrin expression and clustering affects the size of glutamatergic synaptic contacts. J. Neurochem. 104, 830\u2013845 (2008).","journal-title":"J. Neurochem."},{"key":"22742_CR18","first-page":"353","volume":"1","author":"E Head","year":"2012","unstructured":"Head, E., Powell, D., Gold, B. T. & Schmitt, F. A. Alzheimer\u2019s disease in down syndrome. Eur. J. Neurodegener. Dis. 1, 353\u2013364 (2012).","journal-title":"Eur. J. Neurodegener. Dis."},{"key":"22742_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pneurobio.2009.01.008","volume":"88","author":"F Eusebi","year":"2009","unstructured":"Eusebi, F., Palma, E., Amici, M. & Miledi, R. Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: a potent tool for expanding functional information. Prog. Neurobiol. 88, 32\u201340 (2009).","journal-title":"Prog. Neurobiol."},{"key":"22742_CR20","doi-asserted-by":"publisher","first-page":"10973","DOI":"10.1073\/pnas.0804386105","volume":"105","author":"A Limon","year":"2008","unstructured":"Limon, A., Reyes-Ruiz, J. M. & Miledi, R. Microtransplantation of neurotransmitter receptors from postmortem autistic brains to Xenopus oocytes. Proc. Natl Acad. Sci. USA 105, 10973\u201310977 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22742_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.drudis.2018.10.015","volume":"24","author":"R Zwart","year":"2018","unstructured":"Zwart R., Mazzo F. & Sher E. Microtransplantation of human brain receptors into oocytes to tackle key questions in drug discovery. Drug Discov. Today24, 533\u2013543\u00a0(2018).","journal-title":"Drug Discov. Today"},{"key":"22742_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/jnc.13675","volume":"138","author":"F Mazzo","year":"2016","unstructured":"Mazzo, F. et al. Reconstitution of synaptic Ion channels from rodent and human brain in Xenopus oocytes: a biochemical and electrophysiological characterization. J. Neurochem. 138, 384\u2013396 (2016).","journal-title":"J. Neurochem."},{"key":"22742_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1098\/rspb.1984.0027","volume":"221","author":"CB Gundersen","year":"1984","unstructured":"Gundersen, C. B., Miledi, R. & Parker, I. Glutamate and kainate receptors induced by rat brain messenger RNA in Xenopus oocytes. Proc. R. Soc. Lond. B Biol. Sci. 221, 127\u2013143 (1984).","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"22742_CR24","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1523\/JNEUROSCI.6761-10.2011","volume":"31","author":"Y Levchenko-Lambert","year":"2011","unstructured":"Levchenko-Lambert, Y., Turetsky, D. M. & Patneau, D. K. Not all desensitizations are created equal: physiological evidence that AMPA receptor desensitization differs for kainate and glutamate. J. Neurosci. 31, 9359\u20139367 (2011).","journal-title":"J. Neurosci."},{"key":"22742_CR25","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/0896-6273(93)90220-L","volume":"11","author":"KM Partin","year":"1993","unstructured":"Partin, K. M., Patneau, D. K., Winters, C. A., Mayer, M. L. & Buonanno, A. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11, 1069\u20131082 (1993).","journal-title":"Neuron"},{"key":"22742_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","volume":"6","author":"J Neddens","year":"2018","unstructured":"Neddens, J. et al. Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 6, 52 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"22742_CR27","unstructured":"Miller J. A. et al. Neuropathological and transcriptomic characteristics of the aged brain. Elife 6, e31126 (2017)."},{"key":"22742_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1326-7-23","volume":"7","author":"NL Bjorklund","year":"2012","unstructured":"Bjorklund, N. L. et al. Absence of amyloid beta oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer\u2019s disease neuropathology. Mol. Neurodegener. 7, 23 (2012).","journal-title":"Mol. Neurodegener."},{"key":"22742_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-011-0826-y","volume":"121","author":"PT Nelson","year":"2011","unstructured":"Nelson, P. T. et al. Alzheimer\u2019s disease is not \u201cbrain aging\u201d: neuropathological, genetic, and epidemiological human studies. Acta Neuropathol. 121, 571\u2013587 (2011).","journal-title":"Acta Neuropathol."},{"key":"22742_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.15252\/msb.20167144","volume":"12","author":"F Edfors","year":"2016","unstructured":"Edfors, F. et al. Gene-specific correlation of RNA and protein levels in human cells and tissues. Mol. Syst. Biol. 12, 883 (2016).","journal-title":"Mol. Syst. Biol."},{"key":"22742_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03819-3","volume":"9","author":"DM Howard","year":"2018","unstructured":"Howard, D. M. et al. Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. Nat. Commun. 9, 1470 (2018).","journal-title":"Nat. Commun."},{"key":"22742_CR32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fnins.2014.00394","volume":"8","author":"LN van de Lagemaat","year":"2014","unstructured":"Van de Lagemaat, L. N. et al. Age-related decreased inhibitory vs. excitatory gene expression in the adult autistic brain. Front. Neurosci. 8, 394 (2014).","journal-title":"Front. Neurosci."},{"key":"22742_CR33","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neuron.2020.02.015","volume":"106","author":"DM Iascone","year":"2020","unstructured":"Iascone, D. M. et al. Whole-neuron synaptic mapping reveals spatially precise excitatory\/inhibitory balance limiting dendritic and somatic spiking. Neuron 106, 566\u2013578 e568 (2020).","journal-title":"Neuron"},{"key":"22742_CR34","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","volume":"47","author":"JC Amatniek","year":"2006","unstructured":"Amatniek, J. C. et al. Incidence and predictors of seizures in patients with Alzheimer\u2019s disease. Epilepsia 47, 867\u2013872 (2006).","journal-title":"Epilepsia"},{"key":"22742_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2018.07.015","volume":"61","author":"F Cortini","year":"2018","unstructured":"Cortini, F., Cantoni, C. & Villa, C. Epileptic seizures in autosomal dominant forms of Alzheimer\u2019s disease. Seizure 61, 4\u20137 (2018).","journal-title":"Seizure"},{"key":"22742_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature13321","volume":"511","author":"M Xue","year":"2014","unstructured":"Xue, M., Atallah, B. V. & Scanziani, M. Equalizing excitation-inhibition ratios across visual cortical neurons. Nature 511, 596\u2013600 (2014).","journal-title":"Nature"},{"key":"22742_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev-neuro-071714-034002","volume":"38","author":"RC Froemke","year":"2015","unstructured":"Froemke, R. C. Plasticity of cortical excitatory-inhibitory balance. Annu. Rev. Neurosci. 38, 195\u2013219 (2015).","journal-title":"Annu. Rev. Neurosci."},{"key":"22742_CR38","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/36103","volume":"391","author":"GG Turrigiano","year":"1998","unstructured":"Turrigiano, G. G., Leslie, K. R., Desai, N. S., Rutherford, L. C. & Nelson, S. B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391, 892\u2013896 (1998).","journal-title":"Nature"},{"key":"22742_CR39","doi-asserted-by":"publisher","first-page":"a005736","DOI":"10.1101\/cshperspect.a005736","volume":"4","author":"G Turrigiano","year":"2012","unstructured":"Turrigiano, G. Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function. Cold Spring Harb. Perspect. Biol. 4, a005736 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"22742_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/A:1024130211265","volume":"31","author":"J DeFelipe","year":"2002","unstructured":"DeFelipe, J., Alonso-Nanclares, L. & Arellano, J. I. Microstructure of the neocortex: comparative aspects. J. Neurocytol. 31, 299\u2013316 (2002).","journal-title":"J. Neurocytol."},{"key":"22742_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1006\/nbdi.1999.0271","volume":"7","author":"SH Zaman","year":"2000","unstructured":"Zaman, S. H. et al. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer\u2019s disease mutation is normalized with a benzodiazepine. Neurobiol. Dis. 7, 54\u201363 (2000).","journal-title":"Neurobiol. Dis."},{"key":"22742_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop, J. J. & Mucke, L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 17, 777\u2013792 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"22742_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0306-4522(99)00047-0","volume":"92","author":"M Mikkonen","year":"1999","unstructured":"Mikkonen, M., Alafuzoff, I., Tapiola, T., Soininen, H. & Miettinen, R. Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer\u2019s disease. Neuroscience 92, 515\u2013532 (1999).","journal-title":"Neuroscience"},{"key":"22742_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/neuro.05.028.2009","volume":"3","author":"V Garcia-Marin","year":"2009","unstructured":"Garcia-Marin, V. et al. Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques. Front. Neuroanat. 3, 28 (2009).","journal-title":"Front. Neuroanat."},{"key":"22742_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.02.002","volume":"97","author":"Y Xu","year":"2012","unstructured":"Xu, Y. et al. Neurotransmitter receptors and cognitive dysfunction in Alzheimer\u2019s disease and Parkinson\u2019s disease. Prog. Neurobiol. 97, 1\u201313 (2012).","journal-title":"Prog. Neurobiol."},{"key":"22742_CR46","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla, R. & Reddy, P. H. Therapeutics of neurotransmitters in Alzheimer\u2019s disease. J. Alzheimers Dis. 57, 1049\u20131069 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"22742_CR47","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/ijms18081813","volume":"18","author":"K Govindpani","year":"2017","unstructured":"Govindpani K. et al. Towards a better understanding of GABAergic remodeling in Alzheimer\u2019s disease. Int. J. Mol. Sci. 18,\u00a01813 (2017).","journal-title":"Int. J. Mol. Sci"},{"key":"22742_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s42003-019-0413-7","volume":"2","author":"ASK Sequeira","year":"2019","unstructured":"Sequeira, A. S. K., Gottlieb, A. & Limon, A. Human brain transcriptome analysis finds region- and subject-specific expression signatures of GABAAR subunits. Commun. Biol. 2, 153 (2019).","journal-title":"Commun. Biol."},{"key":"22742_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-2008-14305","volume":"14","author":"S Agarwal","year":"2008","unstructured":"Agarwal, S., Tannenberg, R. K. & Dodd, P. R. Reduced expression of the inhibitory synapse scaffolding protein gephyrin in Alzheimer\u2019s disease. J. Alzheimers Dis. 14, 313\u2013321 (2008).","journal-title":"J. Alzheimers Dis."},{"key":"22742_CR50","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/01.jnen.0000435847.59828.db","volume":"72","author":"CM Hales","year":"2013","unstructured":"Hales, C. M. et al. Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes. J. Neuropathol. Exp. Neurol. 72, 1009\u20131015 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"22742_CR51","doi-asserted-by":"publisher","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","volume":"287","author":"S Mondragon-Rodriguez","year":"2012","unstructured":"Mondragon-Rodriguez, S. et al. Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J. Biol. Chem. 287, 32040\u201332053 (2012).","journal-title":"J. Biol. Chem."},{"key":"22742_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"A Ittner","year":"2018","unstructured":"Ittner, A. & Ittner, L. M. Dendritic tau in Alzheimer\u2019s disease. Neuron 99, 13\u201327 (2018).","journal-title":"Neuron"},{"key":"22742_CR53","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover, B. R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067\u20131081 (2010).","journal-title":"Neuron"},{"key":"22742_CR54","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.0308627101","volume":"101","author":"MD Greicius","year":"2004","unstructured":"Greicius, M. D., Srivastava, G., Reiss, A. L. & Menon, V. Default-mode network activity distinguishes Alzheimer\u2019s disease from healthy aging: evidence from functional MRI. Proc. Natl Acad. Sci. USA 101, 4637\u20134642 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22742_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/WAD.0000000000000143","volume":"30","author":"ES Lee","year":"2016","unstructured":"Lee, E. S. et al. Default mode network functional connectivity in early and late mild cognitive impairment: results from the Alzheimer\u2019s disease neuroimaging initiative. Alzheimer Dis. Assoc. Disord. 30, 289\u2013296 (2016).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"22742_CR56","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito, J. R. et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913\u2013922 (2005).","journal-title":"Neuron"},{"key":"22742_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/brain.2014.0266","volume":"5","author":"JN Vega","year":"2015","unstructured":"Vega, J. N., Hohman, T. J., Pryweller, J. R., Dykens, E. M. & Thornton-Wells, T. A. Resting-state functional connectivity in individuals with down syndrome and williams syndrome compared with typically developing controls. Brain Connect. 5, 461\u2013475 (2015).","journal-title":"Brain Connect."},{"key":"22742_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/bpa.12779","volume":"30","author":"JC Lauterborn","year":"2020","unstructured":"Lauterborn, J. C. et al. Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease. Brain Pathol. 30, 319\u2013331 (2020).","journal-title":"Brain Pathol."},{"key":"22742_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65377-3","volume":"10","author":"P Scaduto","year":"2020","unstructured":"Scaduto, P., Sequeira, A., Vawter, M. P., Bunney, W. & Limon, A. Preservation of global synaptic excitatory to inhibitory ratio during long postmortem intervals. Sci. Rep. 10, 8626 (2020).","journal-title":"Sci. Rep."},{"key":"22742_CR60","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak, H. & Braak, E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol. Aging 16, 271\u2013278 (1995). discussion 278-284.","journal-title":"Neurobiol. Aging"},{"key":"22742_CR61","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"22742_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/WAD.0000000000000132","volume":"30","author":"MB Dick","year":"2016","unstructured":"Dick, M. B., Doran, E., Phelan, M. & Lott, I. T. Cognitive profiles on the severe impairment battery are similar in Alzheimer disease and down syndrome with dementia. Alzheimer Dis. Assoc. Disord. 30, 251\u2013257 (2016).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"22742_CR63","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1523\/JNEUROSCI.0164-07.2007","volume":"27","author":"LY Chen","year":"2007","unstructured":"Chen, L. Y., Rex, C. S., Casale, M. S., Gall, C. M. & Lynch, G. Changes in synaptic morphology accompany actin signaling during LTP. J. Neurosci. 27, 5363\u20135372 (2007).","journal-title":"J. Neurosci."},{"key":"22742_CR64","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1523\/JNEUROSCI.1077-10.2010","volume":"30","author":"L Chen","year":"2010","unstructured":"Chen, L. et al. Physiological activation of synaptic Rac-PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J. Neurosci. 30, 10977\u201310984 (2010).","journal-title":"J. Neurosci."},{"key":"22742_CR65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1083\/jcb.200901084","volume":"186","author":"C Rex","year":"2009","unstructured":"Rex, C. et al. Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J. Cell Biol. 186, 85\u201397 (2009).","journal-title":"J. Cell Biol."},{"key":"22742_CR66","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1523\/JNEUROSCI.16-04-01380.1996","volume":"16","author":"C Hunt","year":"1996","unstructured":"Hunt, C., Schenker, L. & Kennedy, M. PSD-95 is associated with the postsynaptic density and not with the presynaptic membrane at forebrain synapses. J. Neurosci. 16, 1380\u20131388 (1996).","journal-title":"J. Neurosci."},{"key":"22742_CR67","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.1523\/JNEUROSCI.0968-12.2012","volume":"32","author":"R Seese","year":"2012","unstructured":"Seese, R. et al. LTP induction translocates cortactin at distant synapses in wild-type but not Fmr1 knock-out mice. J. Neurosci. 32, 7403\u20137413 (2012).","journal-title":"J. Neurosci."},{"key":"22742_CR68","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1523\/JNEUROSCI.0164-07.2007","volume":"27","author":"L Chen","year":"2007","unstructured":"Chen, L., Rex, C., Casale, M., Gall, C. & Lynch, G. Changes in synaptic morphology accompany actin signaling during LTP. J. Neurosci. 27, 5363\u20135372 (2007).","journal-title":"J. Neurosci."},{"key":"22742_CR69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cyto.a.20031","volume":"60","author":"KH Gylys","year":"2004","unstructured":"Gylys, K. H., Fein, J. A., Yang, F. & Cole, G. M. Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortex. Cytom. A 60, 90\u201396 (2004).","journal-title":"Cytom. A"},{"key":"22742_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15357-x","volume":"7","author":"MM Comerota","year":"2017","unstructured":"Comerota, M. M., Krishnan, B. & Taglialatela, G. Near infrared light decreases synaptic vulnerability to amyloid beta oligomers. Sci. Rep. 7, 15012 (2017).","journal-title":"Sci. Rep."},{"key":"22742_CR71","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0002-9440(10)63436-0","volume":"165","author":"KH Gylys","year":"2004","unstructured":"Gylys, K. H. et al. Synaptic changes in Alzheimer\u2019s disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am. J. Pathol. 165, 1809\u20131817 (2004).","journal-title":"Am. J. Pathol."},{"key":"22742_CR72","unstructured":"Zeppillo T. et al. Functional impairment of cortical AMPA receptors in schizophrenia. Schizophr. Res. Online ahead of print\u00a0(2020)."},{"key":"22742_CR73","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"22742_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"22742_CR75","doi-asserted-by":"crossref","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559\u00a0(2008)","DOI":"10.1186\/1471-2105-9-559"},{"key":"22742_CR76","doi-asserted-by":"publisher","unstructured":"Cox C. D. Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer\u2019s disease. Zenodo,\u00a0https:\/\/doi.org\/10.5281\/zenodo.4558112 (2021).","DOI":"10.5281\/zenodo.4558112"},{"key":"22742_CR77","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1109\/83.366472","volume":"4","author":"JC Yen","year":"1995","unstructured":"Yen, J. C., Chang, F. J. & Chang, S. A new criterion for automatic multilevel thresholding. IEEE Trans. Image Process. 4, 370\u2013378 (1995).","journal-title":"IEEE Trans. Image Process."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22742-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22742-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22742-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T10:09:47Z","timestamp":1699006187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22742-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22742"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22742-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"assertion":[{"value":"27 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2603"}}